Greenbrook TMS Inc. (NASDAQ:GBNH) Receives $16.10 Consensus Price Target from Analysts

Shares of Greenbrook TMS Inc. (NASDAQ:GBNHGet Rating) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $16.10.

Several equities analysts have recently commented on the company. Zacks Investment Research cut Greenbrook TMS from a “hold” rating to a “sell” rating in a research note on Friday. Bloom Burton reissued a “buy” rating on shares of Greenbrook TMS in a research report on Monday, April 4th. Canaccord Genuity Group lowered Greenbrook TMS to a “buy” rating in a research report on Monday, February 7th. Finally, Clarus Securities dropped their price target on Greenbrook TMS from C$8.25 to C$7.50 in a research report on Monday, April 4th.

Hedge funds and other institutional investors have recently modified their holdings of the business. Rockefeller Capital Management L.P. acquired a new stake in Greenbrook TMS in the third quarter worth $109,000. AdvisorShares Investments LLC acquired a new stake in Greenbrook TMS in the third quarter worth $103,000. Virtu Financial LLC bought a new position in shares of Greenbrook TMS in the fourth quarter worth $288,000. Royal Bank of Canada grew its stake in shares of Greenbrook TMS by 243.1% in the third quarter. Royal Bank of Canada now owns 6,848 shares of the company’s stock worth $51,000 after purchasing an additional 4,852 shares in the last quarter. Finally, Masters Capital Management LLC grew its stake in shares of Greenbrook TMS by 55.6% in the fourth quarter. Masters Capital Management LLC now owns 700,000 shares of the company’s stock worth $2,954,000 after purchasing an additional 250,000 shares in the last quarter. 16.73% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Greenbrook TMS stock remained flat at $$2.87 on Friday. The stock had a trading volume of 3,445 shares, compared to its average volume of 16,927. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 2.26. The business’s 50-day simple moving average is $3.25 and its 200-day simple moving average is $4.79. Greenbrook TMS has a 12 month low of $2.73 and a 12 month high of $13.89.

Greenbrook TMS (NASDAQ:GBNHGet Rating) last released its earnings results on Wednesday, March 30th. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.38) by $0.04. Greenbrook TMS had a negative return on equity of 189.28% and a negative net margin of 47.42%. During the same quarter in the previous year, the company posted ($0.60) earnings per share. As a group, equities analysts predict that Greenbrook TMS will post -1.21 earnings per share for the current fiscal year.

About Greenbrook TMS (Get Rating)

Greenbrook Tms, Inc engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Recommended Stories

Analyst Recommendations for Greenbrook TMS (NASDAQ:GBNH)

Receive News & Ratings for Greenbrook TMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenbrook TMS and related companies with MarketBeat.com's FREE daily email newsletter.